Diabetes drug Insulin Basaglar to be withdrawn from Indian market. Here’s why

by The Technical Blogs

[ad_1]

American pharmaceutical company Eli Lilly has announced its decision to withdraw its insulin Glargine product, Basaglar KwikPen, from the Indian market.

This drug, designed for managing type 1 and type 2 diabetes in both adults and children, provides a steady insulin supply throughout the day, assisting in blood sugar regulation.

The company has stated that it will cease importing and marketing the medication after March 5, 2024, as per a public notice published on August 30.

The product is marketed in India by pharmaceutical giant Cipla. The withdrawal decision has been described as a well-considered business move by Eli Lilly, aimed at streamlining its product portfolio in India.

“After careful consideration, Lilly India has decided to discontinue Basaglar KwikPen (insulin Glargine) to streamline our current and future product portfolio in the country,” a company spokesperson told News18.

The company has warned that the medication may not be available in the market post-discontinuation and advised patients to consult their doctors for alternative prescriptions.

The product has been facing stiff competition in the Indian market, coupled with a price ceiling imposed by the National Pharmaceuticals Pricing Authority (NPPA), making it financially unsustainable.

The NPPA has capped the price at Rs 244.13 per ml for insulin Glargine 100IU per ml pens. Despite initial success after its launch by Eli Lilly and Cipla in 2019, the product’s sales volume has been low due to high competition.

The company has stated that it will continue to focus on bringing innovative medicines to India and will keep offering Basaglar insulin in the more commonly used 3 ml cartridge formulation.

Edited By:

Daphne Clarance

Published On:

Sep 14, 2023

[ad_2]

Source link

Related Posts

Leave a Comment

Recent Posts

Pigeons swarm Las Vegas neighborhood, nesting at church Study finds adult female elk are badass and can’t be... Vacancy: some more elephants needed in the bush THE TECHNICAL BLOGS

Our Policies

Userful Links

Shop Stores

Copyright @2020  All Right Reserved - Designed and Developed by DSF SEO COMPANY